ESC 365 - Professor Hugo Ten Cate

Speaker illustration

Professor Hugo Ten Cate

Maastricht University Medical Centre (MUMC), Maastricht (Netherlands (The))

Member of:

Professor in Internal medicine/clinical thrombosis and hemostasis; Director, Thrombosis Expertise Center Adjunct Professor Center for Thrombosis and Haemostasis Mainz University Medical Center Mainz, Germany Graduated in medicine, University of Amsterdam in 1987. PhD thesis on “Clinical and experimental studies with a low molecular weight heparinoid”. 1987. Postdoctoral training Beth Israel Hospital and Harvard Medical School Boston with prof Robert Rosenberg and dr. Ken Bauer 1988-1990. Internal medicine training Slotervaart hospital and Academic Medical Center Amsterdam (completed 1996). Clinical Established investigatorship Dutch Heart Foundation 1996-2002. Fellow, Gutenberg Research College, Gutenberg University, Mainz 2012-2016. Other: Chairman of board, Dutch Federation of Anticoagulation clinics (FNT), FAHA, Member ASH, ESC, and ISTH. Ed boards: JTH, ATVB, PlosOne; Co-Ed in chief Thromb J.

Presentations Articles

Acute coronary syndrome

Event: ESC Congress 2023

Topic: Cardiovascular Pharmacotherapy

Session: What does the future hold for factor XIa vs. factor Xa inhibitors in atrial fibrillation, acute coronary syndrome and stroke?

The patient in the intensive care unit

Event: ESC Congress 2023

Topic: Cardiovascular Pharmacotherapy

Session: Antithrombotic therapies in patients with severe infections: COVID-19 and more

Ongoing preclinical and clinical trials on FXIa and FXIIa

Event: EuroThrombosis and EuroVessels 2022

Topic: Thrombosis, Bleeding

Session: Update on antithrombotic strategies

Circulating plasma markers of coagulation and fibrinolysis

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Biomarkers

Session: Biomarkers in arterial thrombosis

Pleiotropic effects of anti-thrombotic therapies in cardiovascular prevention.

Event: ESC Congress 2020

Topic: Basic Science, Other

Session: Thrombosis, Coagulation and Cardiovascular Risk

Targeting new coagulation factors in atherothrombosis.

Event: ESC Congress 2020

Topic: Pharmacology and Pharmacotherapy, Other

Session: Atherothrombosis: New Therapeutic Targets

ESC 365 is supported by